FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091794257> ?p ?o ?g. }

• W2091794257 endingPage "4296" @default.
• W2091794257 startingPage "4287" @default.
• W2091794257 abstract "A new series of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines bearing various substituents at both the N5-pyrimidinyl and N8-pyrazolyl positions have been synthesized, and their binding affinities at the four human adenosine receptor subtypes (hA(1), hA(2A), hA(2B), and hA(3)) have been evaluated. All the described compounds contain arylacetyl moieties at the N5 position and arylalkyl substituents at the N8 position. Surprisingly, all the compounds present their most potent affinities at the hA(2B) adenosine receptor with a range of selectivities against the other subtypes. When bulky groups are present simultaneously at the N5 and N8 positions (e.g., compound 9), the best selectivity for the hA(2B) receptor was observed (K(i)(hA(1)) = 1100 nM; K(i)(hA(2A)) = 800 nM; K(i)(hA(2B)) = 20 nM; K(i)(hA(3)) = 300 nM, K(i)(hA(1)/A(2B)) = 55, K(i)(hA(2A)/A(2B)) = 40, K(i)(hA(3)/hA(2B)) = 15). To understand the molecular significance of these results, we compared the putative TM (transmembrane) binding motif of compound 9 on both hA(2B) and hA(3) receptors. From our docking studies, compound 9 fits neatly inside the TM region of the hA(2B) receptor but not in the corresponding hA(3) region, illustrating significant differences between the two subtypes. The study herein presented permits an understanding of why the bioisosteric replacement of an -NH, present in previously reported hA(3) receptor antagonists, with a -CH(2) group at the N5 position induces such large differences in hA(2B)/hA(3) affinity. In the molecular structure of the hA(3) receptor, two residues, Ser243 (TM6) and Ser271 (TM7), create a hydrophilic region, which seems to permit a better accommodation of the phenylurea series into this putative hA(3) binding site than the phenylacetyl series." @default.
• W2091794257 created "2016-06-24" @default.
• W2091794257 creator A5005359208 @default.
• W2091794257 creator A5007536978 @default.
• W2091794257 creator A5008583952 @default.
• W2091794257 creator A5008712793 @default.
• W2091794257 creator A5009879559 @default.
• W2091794257 creator A5018360276 @default.
• W2091794257 creator A5020435407 @default.
• W2091794257 creator A5026868070 @default.
• W2091794257 creator A5027330772 @default.
• W2091794257 creator A5081526659 @default.
• W2091794257 date "2003-08-30" @default.
• W2091794257 modified "2023-10-15" @default.
• W2091794257 title "Pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidine Derivatives as Adenosine Receptor Antagonists. Influence of the N5 Substituent on the Affinity at the Human A₃ and A_2B Adenosine Receptor Subtypes: A Molecular Modeling Investigation" @default.
• W2091794257 cites W1559630327 @default.
• W2091794257 cites W1969170402 @default.
• W2091794257 cites W1972068315 @default.
• W2091794257 cites W1975304761 @default.
• W2091794257 cites W1995266165 @default.
• W2091794257 cites W1999820883 @default.
• W2091794257 cites W2037591811 @default.
• W2091794257 cites W2080008373 @default.
• W2091794257 cites W2101535048 @default.
• W2091794257 cites W2122199548 @default.
• W2091794257 cites W2149963584 @default.
• W2091794257 cites W2156032902 @default.
• W2091794257 cites W4233297510 @default.
• W2091794257 cites W4293247451 @default.
• W2091794257 doi "https://doi.org/10.1021/jm030852k" @default.
• W2091794257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13678407" @default.
• W2091794257 hasPublicationYear "2003" @default.
• W2091794257 type Work @default.
• W2091794257 sameAs 2091794257 @default.
• W2091794257 citedByCount "55" @default.
• W2091794257 countsByYear W20917942572012 @default.
• W2091794257 countsByYear W20917942572013 @default.
• W2091794257 countsByYear W20917942572014 @default.
• W2091794257 countsByYear W20917942572015 @default.
• W2091794257 countsByYear W20917942572016 @default.
• W2091794257 countsByYear W20917942572017 @default.
• W2091794257 countsByYear W20917942572019 @default.
• W2091794257 countsByYear W20917942572020 @default.
• W2091794257 countsByYear W20917942572023 @default.
• W2091794257 crossrefType "journal-article" @default.
• W2091794257 hasAuthorship W2091794257A5005359208 @default.
• W2091794257 hasAuthorship W2091794257A5007536978 @default.
• W2091794257 hasAuthorship W2091794257A5008583952 @default.
• W2091794257 hasAuthorship W2091794257A5008712793 @default.
• W2091794257 hasAuthorship W2091794257A5009879559 @default.
• W2091794257 hasAuthorship W2091794257A5018360276 @default.
• W2091794257 hasAuthorship W2091794257A5020435407 @default.
• W2091794257 hasAuthorship W2091794257A5026868070 @default.
• W2091794257 hasAuthorship W2091794257A5027330772 @default.
• W2091794257 hasAuthorship W2091794257A5081526659 @default.
• W2091794257 hasConcept C118792377 @default.
• W2091794257 hasConcept C159110408 @default.
• W2091794257 hasConcept C161790260 @default.
• W2091794257 hasConcept C170493617 @default.
• W2091794257 hasConcept C185592680 @default.
• W2091794257 hasConcept C2778689049 @default.
• W2091794257 hasConcept C2778938600 @default.
• W2091794257 hasConcept C2779321679 @default.
• W2091794257 hasConcept C2780283098 @default.
• W2091794257 hasConcept C41685203 @default.
• W2091794257 hasConcept C55493867 @default.
• W2091794257 hasConcept C67907053 @default.
• W2091794257 hasConcept C71240020 @default.
• W2091794257 hasConcept C71924100 @default.
• W2091794257 hasConceptScore W2091794257C118792377 @default.
• W2091794257 hasConceptScore W2091794257C159110408 @default.
• W2091794257 hasConceptScore W2091794257C161790260 @default.
• W2091794257 hasConceptScore W2091794257C170493617 @default.
• W2091794257 hasConceptScore W2091794257C185592680 @default.
• W2091794257 hasConceptScore W2091794257C2778689049 @default.
• W2091794257 hasConceptScore W2091794257C2778938600 @default.
• W2091794257 hasConceptScore W2091794257C2779321679 @default.
• W2091794257 hasConceptScore W2091794257C2780283098 @default.
• W2091794257 hasConceptScore W2091794257C41685203 @default.
• W2091794257 hasConceptScore W2091794257C55493867 @default.
• W2091794257 hasConceptScore W2091794257C67907053 @default.
• W2091794257 hasConceptScore W2091794257C71240020 @default.
• W2091794257 hasConceptScore W2091794257C71924100 @default.
• W2091794257 hasIssue "20" @default.
• W2091794257 hasLocation W20917942571 @default.
• W2091794257 hasLocation W20917942572 @default.
• W2091794257 hasOpenAccess W2091794257 @default.
• W2091794257 hasPrimaryLocation W20917942571 @default.
• W2091794257 hasRelatedWork W1974573029 @default.
• W2091794257 hasRelatedWork W1984949433 @default.
• W2091794257 hasRelatedWork W1996937817 @default.
• W2091794257 hasRelatedWork W2035567885 @default.
• W2091794257 hasRelatedWork W2143619931 @default.
• W2091794257 hasRelatedWork W2311228442 @default.
• W2091794257 hasRelatedWork W2914212586 @default.
• W2091794257 hasRelatedWork W4241081643 @default.
• W2091794257 hasRelatedWork W4311320620 @default.
• W2091794257 hasRelatedWork W783624308 @default.

• next